|
Book Title: Treating and Preventing Adolescent Mental Health Disorders
> pp. [729]
UNDEFINED: AUTHORS
Treating and Preventing Adolescent Mental Health Disorders
Print ISBN 9780195173642, 2005
pp. [729]
Drug Abuse Collaborative Cocaine Study. Archives of General Psychiatry, 56, 495–502.
Crome, I. B., Christian, J., & Green, C. (1998). Tip of the national iceberg? Profile of adolescent subjects prescribed methadone in an innovative community drug service. Drugs: Education, Prevention and Policy, 5, 195–197.
Crowley, J. J., Oslin, D. W., Patkar, A. A., Gottheil, E., DeMaria, P. A., Jr., O'Brien, C. P., et al. (2003). A genetic association study of the mu opioid receptor and severe opioid dependence. Psychiatric Genetics, 13, 169–173.
Crowley, T. J., & Riggs, P. D. (1995). Adolescent substance use disorder with conduct disorder and comorbid conditions. In D. Czechowicz (Ed.), NIDA research monograph 156: Adolescent drug abuse: Clinical assessment and therapeutic interventions (Vol. 156, pp. 49–111). Rockville, MD: National Institute on Drug Abuse.
Dackis, C. A., & Gold, M. S. (1992). Psychiatric hospitals for treatment of dual diagnosis. In J. H. Lowinson (Ed.), Substance abuse, a comprehensive textbook (2nd ed., pp. 467–485). Baltimore: Williams & Wilkins.
Dackis, C. A., Lynch, K. G., Yu, E., Samaha, F. F., Kampman, K. M., Cornish, J. W., et al. (2003). Modafinil and cocaine: A double-blind, placebo-controlled drug interaction study. Drug and Alcohol Dependence, 70, 29–37.
Dackis, C. A., & O'Brien, C. P. (2003b). The neurobiology of addiction. In A. Asbury, G. McKhann, W. McDonald, P. Goadsby, & J. McArthur (Eds.), Diseases of the nervous system (3rd ed., pp. 431–444). Cambridge, UK: Cambridge University Press.
Dackis, C. A., & O'Brien, C. P. (2003a). Glutamatergic agents for cocaine dependence. Annals of the New York Academy of Science, 103, 1–18.
Dackis, C., Yu, E., Samaha, F., Kampman, K., Cornish, J., Rowan, A., et al. (2001). Modafinil—Cocaine safety study; a double-blind, placebo-controlled drug interaction study. College on Problems of Drug Dependence, Presented at the Annual Meeting at San Juan, Puerto Rico.
Daglish, M. R., Weinstein, A., Malizia, A. L., Wilson, S., Melichar, J. K., Britten, S., et al. (2001).
Changes in regional cerebral blood flow elicited by craving memories in abstinent opiate-dependent subjects. American Journal of Psychiatry, 158, 1680–1686.
Daumann, J., Schnitker, R., Weidemann, J., Schnell, K., Thron, A., & Gouzoulis-Mayfrank, E. (2003). Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users. Neuroreport, 14, 1983–1987.
Davies, R., Gabbert, S., & Riggs, P. D. (2001). Anxiety disorders in neurologic illness. Current Treatment Options in Neurology, 3, 333–346.
Daviss, W. B., Bentivoglio, P., Racusin, R., Brown, K. M., Bostic, J. Q., & Wiley, L. (2001). Bupropion sustained release in adolescents with comorbid attention-deficit/hyperactivity disorder and depression. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 307–314.
Deas, D., Riggs, P., Langenbucher, J., Goldman, M., & Brown, S. (2000). Adolescents are not adults: Developmental considerations in alcohol users. Alcoholism, Clinical and Experimental Research, 24, 232–237.
Deas, D., & Thomas, S. (2002). Comorbid psychiatric factors contributing to adolescent alcohol and other drug use. Alcohol Research and Health, 26, 116–121.
Deas-Nesmith, D., Campbell, S., & Brady, K. T. (1998). Substance use disorders in an adolescent inpatient psychiatric population. Journal of the National Medical Association, 90, 233–238.
Dennis, M., Titus, J. C., Diamond, G., Donaldson, J., Godley, S. H., Tims, F. M., et al. (2002). The Cannabis Youth Treatment (CYT) experiment: Rationale, study design and analysis plans. Addiction97, 16–34.
Dennis, M. L., & White, M. K. (2003). The effectiveness of adolescent substance abuse treatment: A brief summary of studies through 2001. Bloomington, IL: Chestnut Health Systems.
end p.729
|
|
|
|
